Sachetta Eric purchased $67K of SRTS
Sachetta Eric purchased 20,633 shares of Sensus Healthcare, Inc. (SRTS) at an average of $3.23 ($3.18–$3.29) across 2 trades over 2026-08-26 to 2026-08-27.
How this was made
The 30-second read
Why it matters
The director's purchase modestly raises his ownership but is unlikely to move the stock.
Market read
Limited relevance; typical for small insider purchases.
What to watch
Potential upcoming clinical trial results not disclosed.
Background
SEC Form 4 filing discloses insider transactions for public companies.
Ticker impact
Director Eric Sachetta bought 20,633 shares for $66.7K, increasing his stake to 229,943 shares.
Minimal short-term price movement expected.
Purchase size is modest relative to market cap; typical insider buying effect is muted.
Market effects
None
None
None
Counterpoint
Insider buying could be a precursor to upcoming positive news.
Key entities
- CompanySensus Healthcare, Inc.
Biopharma company listed under ticker SRTS.
- InsiderEric Sachetta
Director of Sensus Healthcare.